Joerg Weiske - Concepedia

Author

Joerg Weiske

Bayer (Germany)

Also Known As

J. Weiske, Joerg Weiske

Publications

775

Citations

H-Index

Concepts

All Affiliations

Bayer (Germany)Freie Universität Berlin

About

Joerg Weiske is an author at Bayer (Germany) specializing in medicine, biochemistry, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	244
2	Natural Sciences	3	3	159
3	Biochemistry	3	3	159
4	Cell Biology	3	3	156
5	Chemical Biology	2	2	128

Joerg Weiske

Publications

762

Citations

H-Index

Page 1

	Year	Citations
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction R.C. Hillig, Brice Sautier, Jens Schroeder, Proceedings of the National Academy of Sciences	2019	363
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action Amaury E. Fernández‐Montalván, Markus Berger, Benno Kuropka, ACS Chemical Biology Atad2 Bromodomain DimerizationEpigenetic ChangeGeneticsNovel Chemical StructureGenomic Mechanism	2017	88
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer Sebastian M. Dieter, Christine Siegl, Paula Codó, Cell Reports Tumor BiologyOncologyChemoprevention StrategyMedicineColorectal Cancer	2021	85
Nuclear Translocation Uncovers the Amyloid Peptide Aβ42 as a Regulator of Gene Transcription* Christian Barucker, Anja Harmeier, Joerg Weiske, Journal of Biological Chemistry	2014	74
Identification of Small Molecules that Modulate Mutant p53 Condensation Clara Lemos, Luise Schulze, Joerg Weiske, iScience	2020	56
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2-<i>d</i>]pyrimidine Based <i>in Vitro</i> Probe <b>BAY-885</b> for the Kinase ERK5 Duy Nguyen, Clara Lemos, Lars Wortmann, Journal of Medicinal Chemistry Cell DeathMolecular BiologyChemical BiologyPharmaceutical ChemistryTumor Biology	2018	40
Cell-Based Protein Stabilization Assays for the Detection of Interactions between Small-Molecule Inhibitors and BRD4 Jessica Schulze, Dieter Moosmayer, Joerg Weiske, SLAS DISCOVERY Drug TargetMolecular BiologySmall-molecule InhibitorsCancer BiologyCell Regulation	2014	31
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening Stefan Gradl, H. Steuber, Joerg Weiske, SLAS DISCOVERY	2021	25

Page 1